VOLV.A

314

+3.22%↑

ASSA.B

344.3

+2.56%↑

SEB.A

177.2

+2.81%↑

SAAB.B

661.4

+7.63%↑

LIFCO.B

286.2

+0.92%↑

VOLV.A

314

+3.22%↑

ASSA.B

344.3

+2.56%↑

SEB.A

177.2

+2.81%↑

SAAB.B

661.4

+7.63%↑

LIFCO.B

286.2

+0.92%↑

VOLV.A

314

+3.22%↑

ASSA.B

344.3

+2.56%↑

SEB.A

177.2

+2.81%↑

SAAB.B

661.4

+7.63%↑

LIFCO.B

286.2

+0.92%↑

VOLV.A

314

+3.22%↑

ASSA.B

344.3

+2.56%↑

SEB.A

177.2

+2.81%↑

SAAB.B

661.4

+7.63%↑

LIFCO.B

286.2

+0.92%↑

VOLV.A

314

+3.22%↑

ASSA.B

344.3

+2.56%↑

SEB.A

177.2

+2.81%↑

SAAB.B

661.4

+7.63%↑

LIFCO.B

286.2

+0.92%↑

Search

Nolato AB

Cerrado

48.72 2.05

Resumen

Variación precio

24h

Actual

Mínimo

47.6

Máximo

49.08

Métricas clave

By Trading Economics

Ingresos

-64M

151M

Ventas

-70M

2.3B

P/B

Media del Sector

16.431

57.257

BPA

0.56

Rentabilidad por dividendo

3.6

Margen de beneficios

6.646

Empleados

5,491

EBITDA

-47M

370M

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

3.60%

2.27%

Próximas Ganancias

6 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-3B

13B

Apertura anterior

46.67

Cierre anterior

48.72

Nolato AB Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

31 mar 2026, 23:31 UTC

Acciones populares

Stocks to Watch: Nike, RH, NCino

31 mar 2026, 22:35 UTC

Ganancias

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1 abr 2026, 00:00 UTC

Adquisiciones, fusiones, absorciones

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31 mar 2026, 23:50 UTC

Adquisiciones, fusiones, absorciones

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31 mar 2026, 23:43 UTC

Charlas de Mercado

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31 mar 2026, 23:33 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31 mar 2026, 23:21 UTC

Ganancias

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31 mar 2026, 23:14 UTC

Charlas de Mercado
Ganancias

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31 mar 2026, 23:12 UTC

Charlas de Mercado

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31 mar 2026, 22:36 UTC

Ganancias

China Vanke 2025 Loss Widens >000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31 mar 2026, 21:46 UTC

Adquisiciones, fusiones, absorciones

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31 mar 2026, 21:36 UTC

Charlas de Mercado

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31 mar 2026, 21:35 UTC

Ganancias

Nike Expects China Sales Down 20% in 4Q, CFO Says

31 mar 2026, 21:35 UTC

Ganancias

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31 mar 2026, 21:35 UTC

Ganancias

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31 mar 2026, 21:33 UTC

Adquisiciones, fusiones, absorciones

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31 mar 2026, 21:33 UTC

Ganancias

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31 mar 2026, 21:32 UTC

Ganancias

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31 mar 2026, 21:28 UTC

Ganancias

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31 mar 2026, 21:26 UTC

Ganancias

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31 mar 2026, 21:25 UTC

Ganancias

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31 mar 2026, 21:24 UTC

Charlas de Mercado
Ganancias

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31 mar 2026, 21:22 UTC

Ganancias

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31 mar 2026, 21:22 UTC

Ganancias

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31 mar 2026, 21:21 UTC

Ganancias

Nike's Digital Channel Still Too Promotional, CFO Says

31 mar 2026, 21:20 UTC

Ganancias

Nike CEO: Converse Remains Important to Portfolio

Comparación entre iguales

Cambio de precio

Nolato AB previsión

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Nolato AB

Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products for medical technology, pharmaceutical, consumer electronics, telecom, automotive, hygiene, and other industrial sectors in Sweden, Other Nordic countries, Asia, Rest of Europe, and North America, and internationally. The company offers consumables and reusable labware for clinical, chemical, forensic, research, and industrial testing laboratories; develops and supports injection molding and assembly of products; laboratory products, including microtubes, deep-well plates, pipettes, containers and lids, spoons, and cups; breathing bags and catheter balloons; assemblies and post-processing services; and products for primary pharmaceutical packaging, as well as for solids, creams, and ophthalmic products. It designs, develops, and produces advanced components, subsystems, and ready-packaged electronics products, such as laser applications and ceramics, fitness trackers, loudspeaker systems, thermostats, webcams, and vaporiser heating; plastic components, conductive silicone, and thermal interface materials for telecom industry; develops, produces, and assemblies automotive products; EMI shielding, thermal interface materials, and silicone sealing and damping solutions; and supplies plastic components and assemblies for coffee machines and blenders. In addition, the company offers contract manufacturer, virtual prototyping, injection molding of plastics and silicone; injection blow, scientific and ceramic injection, and dip molding; sponge extrusion; micro and compression molding; decoration and die cutting technologies; tool manufacturing; assembly solution, cleanroom production, flatbed punching, laser-activated bonding, and design solutions. The company was formerly known as Nordiska Latexfabriken i Torekov AB and changed its name to Nolato AB (publ) in 1982. Nolato AB (publ) was founded in 1938 and is headquartered in Torekov, Sweden.
help-icon Live chat